Pharmacology - Page 1 | CARLAT PUBLISHING

Clinical Update

Pharmacological Treatments for Autism

August 1, 2026

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC. Shiyu Chen, MD. Chief resident, Family Health Centers at NYU Langone Psychiatry Residency Program, Department of Psychiatry, Brooklyn, NY.

The authors have no financial relationships with companies related to this material.

No drug targets autism’s core symptoms, but medications from antipsychotics to leucovorin can address irritability, sleep, attention, and other co-occurring challenges.

Free Sample Resource - Most Common Clinically Significant Drug Interactions in Psychiatry

June 6, 2026

Victoria Hendrick, MD and Daniel Carlat, MD

Drug-drug interactions are critical to monitor in older adults due to the high prevalence of polypharmacy in this population.

Clinical Guidance

How to Choose the Right Medications for Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The purpose of this fact sheet is not to provide details on pharmacology or the use of these medications, but rather to help you decide which might be best for a given patient.

Clinical Guidance

Substance Use Medications for Children and Adolescents

September 22, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The primary treatment of substance use disorders in teens remains behavioral therapies, particularly motivational interviewing, as well as harm reduction measures.